BioLife Solutions director sells 2,000 shares of company stock
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
BioLife Solutions Inc. director Amy DuRoss reported a sale of company stock. On 12/15/2025, she sold 2,000 shares of BioLife Solutions common stock at a price of $24.6 per share. After this transaction, she beneficially owned 18,687 shares, held directly.
Insider Trade Summary
Net Seller: 2,000 shares
Net Sell
1 txn
Insider
DuRoss Amy
Role
Director
Sold
2,000 shs ($49K)
Share of Position Sold
9.7%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,000 | $24.60 | $49K |
Holdings After Transaction:
Common Stock — 18,687 shares (Direct)
Holdings Before and After:
Common Stock, 20,687 to 18,687 shares (Direct)
Other Insiders: 5 other insiders reported open-market sales of this stock in the 30 days up to this filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.